- Home
- BCYC vs MEGI Comparison
BCYC vs MEGI Comparison
Compare BCYC & MEGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCYC
- MEGI
- Stock Information
- Founded
- BCYC 2009
- MEGI 2021
- Country
- BCYC United Kingdom
- MEGI United States
- Employees
- BCYC N/A
- MEGI N/A
- Industry
- BCYC Biotechnology: Pharmaceutical Preparations
- MEGI Investment Managers
- Sector
- BCYC Health Care
- MEGI Finance
- Exchange
- BCYC Nasdaq
- MEGI Nasdaq
- Market Cap
- BCYC 581.7M
- MEGI 689.1M
- IPO Year
- BCYC 2019
- MEGI N/A
- Fundamental
- Price
- BCYC $8.34
- MEGI $13.65
- Analyst Decision
- BCYC Buy
- MEGI
- Analyst Count
- BCYC 10
- MEGI 0
- Target Price
- BCYC $25.00
- MEGI N/A
- AVG Volume (30 Days)
- BCYC 401.9K
- MEGI 178.0K
- Earning Date
- BCYC 05-01-2025
- MEGI 01-01-0001
- Dividend Yield
- BCYC N/A
- MEGI 11.40%
- EPS Growth
- BCYC N/A
- MEGI N/A
- EPS
- BCYC N/A
- MEGI N/A
- Revenue
- BCYC $25,722,000.00
- MEGI N/A
- Revenue This Year
- BCYC N/A
- MEGI N/A
- Revenue Next Year
- BCYC $0.27
- MEGI N/A
- P/E Ratio
- BCYC N/A
- MEGI N/A
- Revenue Growth
- BCYC N/A
- MEGI N/A
- 52 Week Low
- BCYC $6.10
- MEGI $10.63
- 52 Week High
- BCYC $28.67
- MEGI $14.89
- Technical
- Relative Strength Index (RSI)
- BCYC 49.88
- MEGI 61.41
- Support Level
- BCYC $7.95
- MEGI $13.32
- Resistance Level
- BCYC $9.55
- MEGI $13.70
- Average True Range (ATR)
- BCYC 0.72
- MEGI 0.23
- MACD
- BCYC 0.05
- MEGI 0.05
- Stochastic Oscillator
- BCYC 43.98
- MEGI 83.28
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
About MEGI MainStay CBRE Global Infrastructure Megatrends Term Fund
MainStay CBRE Global Infrastructure Megatrends Fund is a non-diversified, closed-end management investment company. The Fund's investment objective is to seek a high level of total return with an emphasis on current income. It invests predominantly in income-producing equity securities issued by infrastructure companies, including common stock, preferred stock, convertible securities, and rights or warrants to buy common stocks. The company intends to focus on three infrastructure megatrends: decarbonization, digital transformation, and asset modernization while making its investments.